[Sodium 3,4-5-trimethoxy-benzoyl-epsilon-amino-caproate (C-tre) in the treatment of acute myocardial infarct].
D000208:Acute Disease; D000614:Aminocaproates / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D001565:Benzoates / Q000627:therapeutic use*; D001786:Blood Glucose / Q000032:analysis; D001799:Blood Sedimentation; D003402:Creatine Kinase / Q000097:blood; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy*
D000614:Aminocaproates; D001565:Benzoates; D001786:Blood Glucose; D001219:Aspartate Aminotransferases; D003402:Creatine Kinase
Il 3,4-5-trimetossi-benzoil-epsilon-amino-caproato sodico (C-tre) nel trattamento dell'infarto acuto miocardico.